AWH | Aspira Women's Health Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	0.8137 - 0.9075
52 Week Range	0.8100 - 6.10
Beta	2.27
Implied Volatility	459.69%
IV Rank	39.25%
Day's Volume	43,994
Average Volume	134,922
Shares Outstanding	16,062,899
Market Cap	13,822,125
Sector	Healthcare
Industry	Medical - Diagnostics & Research
IPO Date	2000-10-02

Valuation
Profitability
Growth
Health
P/E Ratio	-0.61
Forward P/E Ratio	-1.47
EPS	-1.42
1YR Price Target	4.50
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	64
Country	USA
Website	AWH

Aspira Womens Health Inc is transforming women's health with the discovery, development, and commercialization of testing options and bio-analytical solutions that help physicians assess risk, optimize patient management and improve gynecologic health outcomes for women. OVA1 plus combines its FDA-cleared products OVA1 and OVERA to detect the risk of ovarian malignancy in women with adnexal masses. Aspira GenetiX testing offers both targeted and more comprehensive genetic testing options with a gynecologic focus. Its focus is on delivering products that allow healthcare providers to stratify risk, facilitate early detection, and optimize treatment.

AWH's peers: BIAFW, ABMC, ARYC, RDNT, BDSX, BNR, STIM, DRIO, GTH, SERA, FONR, OLK, LMDX, XGN

*Chart delayed

Analyzing fundamentals for AWH we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see AWH Fundamentals page.

Watching at AWH technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on AWH Technicals page.